Evidence map›Paper›PMID 30205136›Full record

ReviewReproductive toxicology (Elmsford, N.Y.)2018

Development of a curated Hershberger database.

P Browne, N C Kleinstreuer, P Ceger, C Deisenroth, N Baker, K Markey, R S Thomas, R J Judson, W Casey

Open access · greenAbstract readReview
In one paragraph

Review in Reproductive toxicology (Elmsford, N.Y.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 33 citations in OpenAlex.

  1. Weight of evidence for cross-species conservation of androgen receptor-based biological activity.Toxicological sciences : an official journal of the Society of Toxicology · 2023
    Pooled it
  2. Multimodal Cross-Attentive Graph-Based Framework for Predicting In Vivo Endocrine Disruptors.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Article
  4. Adverse effects in traditional and alternative toxicity tests.Regulatory toxicology and pharmacology : RTP · 2024
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Curated Data In - TrustworthyAlternatives to laboratory animals : ATLA · 2021
    Review
  11. Article
  12. Selecting a minimal set of androgen receptor assays for screening chemicals.Regulatory toxicology and pharmacology : RTP · 2020
    Article
  13. An integrated chemical environment with tools for chemical safety testing.Toxicology in vitro : an international journal published in association with BIBRA · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

P BrowneOECD/EHS, Paris, France. Electronic address: patience.browne@oecd.org.
N C KleinstreuerNIH/NIEHS/DNTP/NICEATM, RTP, NC, USA.
P CegerILS, RTP, NC, USA.
C DeisenrothEPA/ORD/NCCT, RTP, NC, USA.
N BakerLeidos, RTP, NC, USA.
K MarkeyEPA/OSCP, Washington, DC, USA.
R S ThomasEPA/ORD/NCCT, RTP, NC, USA.
R J JudsonEPA/ORD/NCCT, RTP, NC, USA.
W CaseyNIH/NIEHS/DNTP/NICEATM, RTP, NC, USA.
Integrated Laboratory Systems, Inc. · USLeidos (United States) · USOrganisation de Coopération et de Développement Economiques · FR

Funding

Biomolecular Screening and Alternative Approaches for the National Toxicology ProgramZIAES103318 · NIEHS · NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES · PI CASEY, WARREN · 2016 to 2021
$25.0M
Intramural EPA EPA999999
6 · The paper itself

Abstract

A systematic literature review was conducted to identify Hershberger bioassays for ∼3200 chemicals including those used to validate the OECD/US EPA guideline assay, US EPA's chemicals screened for endocrine activity, and the library of chemicals run in US EPA 's ToxCast in vitro assays. For 134 chemicals that met pre-defined criteria, experimental results were extracted into a database used to characterize uncertainty in results and evaluate the concordance of the Hershberger assay with other in vivo rodent studies that measure androgen-responsive endpoints. Of 25 chemicals tested in >1 Hershberger study, 28% had disagreements between studies (i.e. ≥1 positive and ≥1 negative study), and of the 65 chemicals tested in Hershberger studies and other in vivo studies with androgen-responsive endpoints, 43% indicated disagreements, though in some cases these may be explained by differences in study designs or physiology of the animal model. Ultimately, 49 chemicals were identified with reproducible androgen pathway responses confirmed in ≥2 in vivo rodent studies that could be considered reference chemicals useful for validating alternative methods.

Indexed as

Biological AssayAndrogen AntagonistsAndrogensAnimalsHumansAndrogen AntagonistsAndrogensAndrogenicAnti-androgenicDisruptionEDSPEndocrineHershbergerMale reproductionReference chemicalSystematic review

Identifiers

PMID30205136
PMCPMC6711601
OpenAlexW2890900135

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.